Best Practice Software

8 Tips for Improving Workplace Communication in Your Practice

Improving Workplace Communication Blog Post Image

Working on improving workplace communication is paramount for any business, and Medical Practices are no exception.

As a Practice leader, you know that success in your role is dependent on your ability to effectively communicate. But just as important as the quality and value of your own words is the cultural commitment you make to internal communication within your Practice as a busy, high-profile workplace. So how do you make it part of everyday business, and embed it within Practice business strategy to make it “part of what we do around here”?

I recommend promoting the benefits of good workplace communication within your team by outwardly recognising that good communication is fundamental to the success of your Practice as a business. By making communication one of your ‘people pillars’, you’ll ensure less misunderstanding within your team – including Practitioners, Reception, Practice Management, and IT/business support team –, an increased commitment to change, a reinforced role of supervisor as leader, and more active participation in the Practice and its mission.

Think about adopting some shared communication principles within your Practice team, like:

  • Embedding in your team mission your commitment to open, honest, and meaningful internal communication – at all costs, including the potential to damage fragile egos. Embrace the concept that, as leader, you’ll set the highest standard in being transparent and authentic in your communication with the team and invite members to (respectfully) challenge you anytime they think you miss the mark.

  • Embrace face-to-face communication foremost while still recognising e-mail and intranet bulletins as a convenient, but ultimately more impersonal, workplace tool. Sunrise (before clinic) and Sunset (after clinic) personal team or individual briefings will always be more valued when they’re localised, purpose-driven, two-way, … and brief.

  • Utilise the communication tools already built into your business software/systems for instant messaging when you need to raise attention to an urgent or immediate matter – especially between Practitioner and Reception team. There is a great internal messaging feature built in to Bp Premier that many doctors and their Practice team use, providing a useful instant on-screen message if ever required.

  • Value meaningful two-way engagement with your Practice team, ensuring the team knows you will provide (and you welcome back) genuine and constructive feedback on team achievement towards individual and shared goals. Improving workplace communication is a lot easier when your team knows they’re being listened to.

  • Recognise the frontline role your Practitioners and Practice leadership team plays in team engagement – and let your Practice leaders know you expect they will make team communication the first and foremost part of their role as leader and use language which is familiar to and understood by their work group.

  • Ensure your Practice team knows they will be briefed face-to-face on matters which affect their job, and you’ll set that standard yourself. If each employee can’t be consulted and involved in decision-making regarding their job before any major change occurs, they should at least be briefed in person on important matters which change what they do, or how you expect them to do it.

  • Preference communication that promotes action within your team and Practice. We’ve all sat in a meeting that should have been an email, so ensure any team assemblies have a clear and concise purpose (agenda), don’t linger longer than is necessary, and you note and distribute a summary of key action items and accountabilities before anybody leaves.

  • Outline to the team your minimum engagement opportunities. Perhaps make a commitment that, for instance, you’ll host supervisor briefings at least monthly, and supervisor-to-Practice team briefings every second day, and informal ‘toolbox’ chats on health and safety matters or reception/patient matters each Friday morning at 7:30am. This helps ‘lock in’ your time together, and shows you’re wholly committed to these engagements, even if you don’t have much news to share.

While these tips provide a good starting point on the topic, improving workplace communication needs and deserves follow through and actions that match your words, from the senior-most level to the people greeting and treating your patients. By sharing team news early and consistently you’ll help ensure your preferred (rather than speculative) message is heard by every member of your team.

Authored by:

Craig Hodges
Chief Corporate Officer at Best Practice Software

Share this article:

Special Offer for New-to-Tyro Bp Premier Customers

Tyro Eftpos Machine Receipt In Shape Of Heart

The Best Practice Software and Tyro EFTPOS integrated solution can help you to start the new year off right, giving you time back to focus on your patients and Practice.

Best Practice Software and Tyro are offering a Bp Virtual Training session* to the first 24 new-to-Tyro customers who join Tyro by 31 July 2021.

Are you an existing Best Practice Software customer who would benefit from some additional training for your team and practice?

We are offering a whole range of learning opportunities to enable you and your team to get the most from Bp Premier. Choose from a range of online group training courses with one of our experienced trainers who will guide you through content relevant to your role. Bp Virtual online group training brings direct support to your practice and helps to ensure you are maximising the capabilities of Bp Premier. It’s also the perfect opportunity to ask any questions you have.

The added bonus is that all training courses are recorded and will be emailed to you after training, so you can review and playback at a later date or share with new starters that join the team. Bp Virtual courses also come with a certificate of attendance for your records.

Why Tyro:

Tyro’s tailored health solutions are designed to take care of you and your patients. Here are some of the reasons why you’ll love the Best Practice Software and Tyro EFTPOS integrated solution:

  • Seamless integration – give your patients a fast, simple and efficient payment experience with the Tyro and Best Practice Software integrated payment solution
  • Tyro Portal – provides you with customised EFTPOS reporting in one handy location
  • Tyro pricing – competitive pricing tailored for your business
  • Integrated Medicare Easyclaim – offer patients on the spot Medicare rebate with Bp Premier Software
  • Multi-merchant – allowing multiple doctors and bank accounts on the one EFTPOS machine, integrated with your PMS
  • Tyro support – 24/7 Australian-based customer support
  • Lightning-fast speeds – keep queues short with fast transactions
  • Try Tyro for free – no lock-in contract, no set up fees and no cancel/break fees

How Does it Work?

  • Be an existing Best Practice Software customer who signs up to become a new-to-Tyro EFTPOS customer by 31 July 2021; and
  • If eligible, receive a free Best Practice Software Bp Virtual training session of their choice, valued at $275, which can be attended by one Practice staff member*.
  • For more information on Bp Virtual training sessions, click here.

To find out more information about Tyro or the offer, click here and a Tyro payments specialist will be in touch to talk about how Tyro can help your Practice.

*Best Practice Software and Tyro Campaign (Offer) Terms and Conditions

Important information

These Terms and Conditions together with the relevant Best Practice Software Terms and Conditions available at (https://bpsoftware.net/terms-of-use-2) and the relevant Tyro Terms and Conditions available at https://www.tyro.com/terms-and-conditions  govern this Offer. By providing your details to Best Practice Software Pty Ltd (ABN 92 104 808 988) (Best Practice Software) and Tyro Payments Limited (ABN 49 103 575 042) (Tyro), in connection with this Offer, you agree to be legally bound by these Terms and Conditions. ‘you’ and ‘your’ mean the person or persons in whose name the account will be held with Best Practice Software and Tyro.

This Offer is available to existing Best Practice Software customers and new-to-Tyro customers who sign up with Tyro between 9.00am 04 January 2021 (Sydney time) and 5.00pm 31 July 2021 (Sydney time) (Offer Period) (New Customer). This Offer is not applicable in conjunction with any other Best Practice Software and/or Tyro offer. Best Practice Software and Tyro reserve the right to extend or withdraw this Offer at any time at their sole discretion. If Best Practice Software and Tyro withdraw the Offer, Best Practice Software will honour the Offer in respect of all New Customers that have their applications approved by Tyro before the Offer is withdrawn, provided the applicants satisfy all of the Eligibility Criteria. New Customers can cancel a live application at any time in the event that Best Practice Software and Tyro withdraw the Offer.

Subject to the remainder of these Terms and Conditions, the New Customer will receive a free Bp Virtual training session if the New Customer:

  • is an existing Best Practice Software customer located in Australia; and

  • is referred to Tyro by Best Practice Software; and

  • submits their new Tyro EFTPOS Banking Application to Tyro during the Offer Period; and

  • is approved as a Tyro EFTPOS Banking merchant within 30 days of submitting their application; and

  • is one of the first 24 customers to complete the above before 31 July 2021,

(the ‘Eligibility Criteria’). Best Practice Software and Tyro may, in their sole discretion, determine whether or not the Eligibility Criteria are met.

The New Customer is ineligible for the Offer if the New Customer:

  • has previously been a Tyro customer at any time within 6 months prior to the commencement date for the Offer;

  • is an additional terminal or MID (additional account for Tyro) to an existing location that already has a Tyro machine; or

  • is an additional location to an existing ABN.

Provided the Eligibility Criteria are met, the New Customer will be offered one (1) Bp Virtual Training Session valued at $275 (inc. GST) (as detailed here) per ABN per Practice, which can be attended by one staff member of the Practice. The Bp Virtual Training session must be undertaken by 31 December 2021.

Tyro Payments Limited ACN 103 575 042 AFSL 471951 is the issuer of its own financial products. As Tyro does not take into account your personal circumstances, please consider if these products are suitable for you. You can contact Tyro on 02 8907 1700 or tyro.com and access Tyro’s dispute resolution process at tyro.com/complaint-resolution-process/. Tyro may pay financial benefits and/or referral fees to its partners. 2021 © Tyro Payments Limited. All rights reserved
Share this article:

Video: Pathology and Imaging Requests in Bp Premier

Radiology and Imaging Requests in Bp Premier Blog Image

This Bp Premier Be In The Know Session is intended to take learners through the entire workflow for pathology and imaging, from creating requests, to marking results as having been given to patients.

The webinar will cover the following topics:
(Drag the progress bar in the video below to jump to a specific section)
– Creating requests for Pathology [00:54]
– Creating requests for Imaging [06:43]
– Setting up favourites and adding custom tests [12:26]
– Tips and tricks for reviewing results [23:09]
– Managing unallocated results [38:44]
– Marking results as given [44:25]

Watch the video to learn about Pathology and Imaging Requests in Bp Premier!

Share this article:

Best Health App Survey: Give Your Opinion for a Chance to Win

The Best Health App Survey

Seeking Customer Input Through this Best Health App Survey

A customer centric approach and commitment to continuous evolution, to meet the ever-changing demands of healthcare professionals has proudly been the cornerstone of our operations since 2004. We believe this to be a symbiotic relationship where development of our offerings advances alongside our increasingly tech savvy practices and their patients. As such, we’re seeking your input via this Best Health App survey, to help us shape and prioritise our roadmap for the development of our app.

The short survey will only take 10-15 minutes to complete, and focuses on identifying the functionality that is most important to your Practice and patients.

Prize Draw Details

The prize: Win one of three $100 Visa gift cards.

Contest Period: The survey is open from 7:00 am Wednesday 21st April and closes at 11:59pm Monday 10th of May. 

Eligibility: To be included in the prize draw respondents must complete the Best Health App survey online. Only Team Bp customers are eligible. Australian and New Zealand customer feedback welcome.

Date, time and place of draw: The prize draw will be conducted at midday Friday 14th May. Winners will be drawn at random.

Publication of winner names: Winners will be notified by telephone or in writing via email. Please provide your contact details at the end of the survey to be included in the draw.

Share this article:

Video: Helping Practices Prepare for the COVID-19 Vaccine Rollout

Prepare for the COVID-19 Vaccine

An informational session to help practices prepare for the COVID-19 Vaccine Rollout, in particular phase 1B. Our Training specialists will take you through our recommended Bp Premier workflows to support the administration of the COVID-19 vaccine in Bp Premier, including all of the tips/tricks and resources needed to support a successful roll out. The sessions covers the following components:

(Click on the timestamp below to jump to a specific section)
– Overview of Phase 1B [01:29]
– Setting up your Practice [05:46]
– Patient Screening [16:28]
– Patient Bookings [20:37
– Recording Vaccinations [22:54]
– Billing Procedures [31:22]
– Reporting [33:47]
– Resources [36:40]
– Q & A [40:19]

Watch the video to prepare for the COVID-19 Vaccine Rollout in your Practice!

For further tips on the COVID-19 Vaccine Rollout, catch this article, written by Jess White, as she explores some key points to consider as part of your preparation for the vaccine rollout, including how to manage appointment bookings, new patient data, second doses, patient consent, reporting to the AIR, billing and reporting. Don’t miss this invaluable read to help you prepare for the COVID-19 Vaccine Rollout!

Share this article:

Tackle Australia’s Biggest Killer With the Heart Health Check Toolkit for Practices

Heart Health Check Toolkit

Coronary Heart Disease is Australia’s biggest killer. Approximately 2.5 million Australians are at a high risk of suffering a heart attack or stroke in the next five years, and more than half of these have not had an event previously.

Heart Health Checks support the specific assessment and management of absolute CVD risk in primary care for eligible patients 45 years and over (30 years and over for Aboriginal and Torres Strait Islander patients).

The Heart Foundation has launched the new Heart Health Check Toolkit. It is free and available online now to assist GPs, practice nurses and practice managers to streamline the assessment and management of absolute CVD risk. 

The Toolkit is a one-stop shop designed to assist general practice staff to easily assess and manage CVD risk in line with the latest guidance. It offers a range of tools and resources including assessment and management templates, quality improvement tools, patient engagement resources and much more.

By making the Heart Health Check easier to plan, recall and implement as per guidelines, more patients who are at risk of coronary heart disease in Australia will be identified and treated, ultimately lowering the morbidity and mortality of CVD.

“With a specific Heart Health Check item number, it is much easier to track heart health assessments and take a more proactive approach for our patients. The item number also allows us to leverage the use of our practice nurses to streamline the process.” – Associate Professor Ralph Audehm

Five Reasons to Check Out the Heart Health Check Toolkit

  • Pre-filled assessment and management templates make it easier for you to collect CVD risk factor information and support your patients to manage their risk.
  • The ‘quality improvement’ section of the Toolkit has all that your practice needs to kickstart continuous quality improvement as required by the PIP QI program.
  • Re-engaging with your patients about their heart health has never been so important. Our patient invitation templates, receptionist guide and data recall recipes can be used to identify and recall your at-risk patients.
  • Waiting room posters, animations and brochures will help you to engage with your patients about their heart health in an impactful way.
  • Thinking about setting up a heart health promotional event? Our step-by-step guide can be used by the entire team to help you prepare.

For a more information, you can download the Heart Foundation’s Heart Health Check Toolkit Promotional Pack here, which hosts clickable links to the various free tools available to you and your practice.

Share this article:

TARB-Ex: New Free Electronic Screening Tool for Identifying Risk

TARB-Ex Free Screening Tool for Bp Premier

TARB-Ex is a new FREE electronic screening tool for identifying risk of familial hypercholesterolaemia (FH) in general practice, and available now in Bp Premier.

It was developed by Professor Tom Brett, Dr Lakkhina Troeung and colleagues at the General Practice and Primary Health Care Research Unit at the School of Medicine, The University of Notre Dame Australia, Fremantle, Western Australia.

TARB-Ex has been successfully trialled in different Practices Australia-wide and a validated assessment has been undertaken to compare its performance against a GP using a manual approach. A paper1 on TARB-Ex has been published in Heart: Troeung L, et al, titled, ‘A new electronic screening tool for identifying risk of familial hypercholesterolaemia in general practice’.

The extraction tool was used in the NHMRC Partnership Grant study (GNT 1142883) into improving the detection and management of familial hypercholesterolaemia in Australian general practice, involved 15 practices across Australia and was led by Professor Brett. Findings from the study have been accepted for publication in Heart Journal.2

TARB-Ex data extraction tool extracts routine clinical information from the practice electronic health records to derive a Dutch Lipid Score and identifies patients with potential high FH risk for clinical investigation. The extraction tool was developed using Structured Query Language (SQL) technology and written for Bp Premier clinical software.

The tool will isolate all patients seen at the practice over the past two years and who have blood lipids undertaken. You need to have the lipid level recorded to generate a Dutch Lipid Score. This will include patients currently or formerly on medications for lipid reduction and patients not on such medications.

TARB-Ex does not export any data from your health records.

After TARB-Ex data extraction, those patients with Dutch Lipid Scores generated can be prioritised from highest to lowest based on their Uncorrected Dutch Lipid scores. To do this, all patients with Corrected Dutch Lipid scores of 5 and above can be saved to Excel. The patient list can then be prioritised from highest to lowest. The best return for the reviewing GP or PN will be those with the highest Uncorrected scores.

Download this tool for free on our Bp Premier Downloads page here, scrolling down to the Utilities section.

References and related papers

1. Troeung L, Arnold-Reed D, Chan She Ping-Delfos W, Watts G F, Pang J, Lugonja M, Bulsara M, Mortley D, James M, Brett T (2016) A New Electronic Screening Tool for Identifying Risk of Familial Hypercholesterolaemia in General Practice. Heart. 25 February 2016. doi:10.1136/heartjnl-2015-308824

2. Brett T, Chan DC, Radford J, Heal C, Gill G, Hespe C, Vargas-Garcia C, Condon C, Sheil B, Li IW, Sullivan DR, Vickery AW, Pang J, Arnold-Reed DE, Watts GF. Improving detection and management of familial hypercholesterolaemia in Australia general practice. Heart 2021 (In press)

3. Brett T, Arnold-Reed D. Familial Hypercholesterolaemia – a guide for general practice. AJGP 2019; 48: 650-652.

4. Brett T, Qureshi N, Gidding S, Watts GF. Screening for familial hypercholesterolaemia in primary care: time for general practice to play its part. Atherosclerosis 2018; 277: 399-406. Doi.org:10.1016/j.atherosclerosis.2018.08.019

5. Watts GF, Sullivan D, Hare D, Kostner K, Horton A, Bell D, Brett T, Trent R, Poplawski N, Martin A, Srinivasan S, Justo R, Chow C, Pang J. Integrated Guidance for Enhancing the Care of Familial Hypercholesterolaemia in Australia. Heart, Lung and Circulation. 2020. Heart, Lung and Circulation 2020; https://doi.org/10.1016/j.hlc.2020.09.943

6. Brett T, Radford J, Heal C, et al. Implications of new clinical practice guidance on familial hypercholesterolaemia for Australian general practitioners. Submitted AJGP 2021

7. Watts GF, Sullivan D, Hare D, Kostner K, Horton A, Bell D, Brett T, et al. Essentials of a new clinical practice guidance on familial hypercholesterolaemia for physicians. Internal Medicine Journal 2021 (In press)

8. Brett T, Radford J, Qureshi N, Pang J, Watts GW. Evolving worldwide guidelines on lipid management and implications for Australian general practice. AJGP 2021 (In press)

9. Martin AC, Hooper AJ, Norman R, Nguyen LT, Burnett JR, Bell D, Brett T, Garton-Smith J, Pang J, Nowak K, Watts GF.  A pilot study of universal screening of children and child-parent cascade testing for familial hypercholesterolaemia in Australia. Submitted J Paeds and Child Health 2021.

10. Watts GF, Sullivan D, Hare D, Kostner K, Horton A, Bell D, Brett T, et al. Synopsis of Integrated Guidance for Enhancing the Care of Familial Hypercholestolaemia: an Australian perspective. Amer J Prev Cardiology. https://doi.org/10.1016/j.apc.2021.10051

11. Familial Hypercholesterolaemia and Cascade Testing in General Practice – Lessons from Covid-19. Garraghy E, Brett T, Watts GF, Heal C, Hespe C, Radford J. AJGP 2020; 49: 859-860

12. Pang J, Sullivan DR, Brett T, et al. Familial hypercholesterolaemia in 2020: a leading Tier 1 genomic application. Heart, Lung, Circulation 2019), https:// doi.org/10.1016/j.hlc.2019.12.002 

13. Brett T. Case 2: Zehra has vague chest discomfort. Check: Genomics. 2019; 557: 11–16.

Share this article:

Free Access: New Australian Healthcare Index Report

Australian Healthcare Index Report

No COVID slump as majority of Australians satisfied with healthcare system new report finds.

Patients weigh in on GPs, dentists, private health insurance, healthcare costs and more.

Despite a once-in-a-century pandemic still lingering one year on, Australians have given a vote of confidence to the Australian healthcare system, with 65.5% rating it a score of 8 or above out of 10, in a new report capturing the mood of Australian patients. 

The first Australian Healthcare Index report seeks to elevate patient perspectives and experiences on overall healthcare in Australia, based on responses from over 8,000 adults. 

Produced by the Australian Patients Association and HealthEngine, the report captures learnings from patients on the public and private healthcare ecosystem including primary care, private health insurance (PHI), emergency departments, elective surgery, prescription medicine and more.  

Designed to provide a pulse check on healthcare in Australia, key findings include:

  • Patients rated Australian Healthcare 7.8 out of 10
  • Patients are more likely to recommend their GPs than their dentist to friends and colleagues
  • While 55.1% of respondents have private health insurance (PHI), the majority are not recommending their PHI and many feel it costs too much
  • 36.6% think prescription medicine is too expensive
  • Nearly 95% embrace the intersection of healthcare and technology, with the use of, and interest in, telehealth, health apps, online booking, e-scripts and more
HealthEngine CEO, founder and medical director Dr Marcus Tan says the report is testament to the robustness of the healthcare system. 
 
“The fact a majority of Australians have a favourable opinion of the healthcare system after COVID-19 caused disruption, is a credit to the thousands of healthcare professionals with a commitment to patient-centred care.” said Dr Tan.  “With the release of the Australian Healthcare Index, we can identify, share and champion people’s perspectives on healthcare, as well as provide a baseline of learnings to establish a report that will come out twice a year.” 
 
Tan added, “Working closely with the APA, we hope the report drives conversation and consideration for the continued support of a patient-centric approach to healthcare.”  
 
Stephen Mason, CEO of the Australian Patients Association hopes the report will help strengthen patient-centred care in the healthcare system.  
 
“As we advocate for improved patient care and health outcomes, the Australian Healthcare Index is an important pulse check on the patient experience for organisations like ours as well as the greater healthcare community, peak bodies and government at all levels, who are contributing to and leading public and private healthcare in Australia,” said Mason. 
 
“The APA became involved with the Australian Healthcare Index to hear the patient’s voice. Although we are comforted by the knowledge that our healthcare system has coped well during the pandemic, we are concerned about dental care and the cost of medicines.” 
 
“As for the perceived lack of value from PHI, we are working closely with Private Healthcare Australia and its members to address this concern and in particular to prevent excessive out of pocket costs. “We hope the report’s findings make a positive contribution to shaping national healthcare policy, on behalf of patients across the country.” 
 
View or download the the Australian Healthcare Index at AustralianHealthcareIndex.com.au.  An interactive dashboard is available to explore the national survey results and view data at a state level or other demographics. 
 
Article contributed by HealthEngine.
Share this article:

COVID-19 Vaccine Rollout – Preparing Your Practice

COVID-19 Vaccine Rollout Blog Image Vaccine Vials Floating Blue Space

With the 1B COVID-19 Vaccine Rollout beginning across Australia this week, Practices have a lot of moving pieces that need to be considered to support the rollout of the vaccination program at their Practice.

To assist with this process, let us take you through some of the key items for consideration by your Practice.

Vaccine Rollout Setup and Configuration

Ensuring that you are ready to start taking bookings for the 1B COVID-19 Vaccine Rollout is the first step for any Practice. Some key points to focus on:
 
  • Are you using our latest data update?
    The March data update is a pre-requisite for managing COVID-19 vaccinations. We encourage you to check that you have installed the March data update at your Practice. The April data update (when released) will contain COVID-19 vaccination Reasons for Visit and the COVID-19 vaccination consent template.
  • How are your patients making their bookings?
    It is important to consider the different workflows a Patient may use to book an appointment (e.g., in-person, via the Commonwealth Booking Platform and directly via your online appointment vendor) and ensure that you have a consistent booking process implemented. This will guarantee that patients have gone through the required eligibility check, pre-screening and have booked an appointment with the appropriate provider at your Practice. It is also important to consider stock control measures and how you are managing this as part of the appointment booking process.
  • How is your Practice managing the bookings?
    There are a number of ways to configure Bp Premier to support a vaccination clinic. The following options could be considered:
    • Setting up a specific COVID-19 Location
    • Adding dedicated users (in this instance, some Practices have looked at setting up COVID-Dose 1 and COVID-Dose 2 so they can prioritise returning patients if stock levels run low)
    • Adding a new Appointment Type
    • Adjusting Appointment Length
    • Using a new Appointment Book layout
  • How are you managing your patients’ second dose?
    In some instances, a patient may be prompted to make their second booking for their COVID-19 vaccination at the time of making their first booking. It is important to consider how your Practice may manage this scenario to ensure you have adequate stock levels and the required reporting measures in place to ensure they attend their appointment. We recommend checking in with your online appointment vendor to better understand any possible booking workflows and patient follow up/notification procedures as well as establishing your own internal reporting and follow up process using the tools available within Bp Premier (for example Bp SMS recalls and reminders etc.).
  • How are you handling patient consent?
    Patient consent can be obtained in both verbal and written form. The COVID-19 consent form will be made available in Bp Premier as part of the April data update, alternatively this is available on the national COVID-19 website here. We recommend that Practices discuss their preferred process internally and come up with a ‘whole of Practice’ approach.

Recording the COVID-19 Vaccination

It is mandatory to upload all COVID-19 vaccinations to AIR (Australian Immunisation Registry) within 24 hours of the vaccine being administered. Some key points to consider:

  • Check the patient’s COVID-19 vaccination history
    We recommend accessing the patient’s My Health Record or using PRODA to access AIR to verify their current COVID vaccination status.
  • Entering the vaccination
    Users can enter the COVID-19 vaccination information into the standard immunisation Window available in the Bp Premier Clinical Record. It is important to remember to record the expiry date and batch number as these are both mandatory fields.
  • What about the vaccine serial number?
    At this stage, the serial number field is not mandatory – nor do we have enough information about this data field to provide further instructions on how it should be recorded. We are expecting further information on the serial number, including options for scanning the number into our software, in the coming weeks and will distribute a communication containing detailed instructions as soon as this information is made available.
  • Uploading records to AIR
    A reminder that it is mandatory to upload all COVID-19 vaccines to AIR within 24 hours of the vaccine being administered. We recommend that you upload your immunisation lists to AIR daily to ensure that you are meeting these mandatory requirements.
  • Adverse events following immunisation (AEFI)
    Health professionals must manage and report adverse events to their relevant state or territory following an AEFI. As each state and territory has slightly different reporting requirements, please contact your local public health unit for more information.

Billing and Reporting

There are new MBS items and incentives available for the COVID-19 vaccine rollout.

  • COVID-19 MBS items
    These items are available in the March data update, so please ensure that this has been applied at your Practice. MBS incentive items such as 10990 or 10991 are already incorporated in the item value and will not be automatically added to the invoice during billing.
  • PIP eligibility is based on the patient receiving their second dose of their COVID-19 vaccination
    We recommend that Practices run regular reports (using MBS search criteria) to keep track of patients that may not have returned for their second dose.

What Else Should I Know About the COVID-19 Vaccine Rollout?

  • Managing an influx of new patients
    As your Practice will be seeing a number of ‘new’ patients who may attend for vaccination purposes only, it is important to consider how this may impact your Practice Data Set. We recommend tagging these patients using the Record No. field so that they can be archived if needed. Alternatively, you could also use one of our supplied queries to locate patients who have only been to your Practice for the vaccination and archive them this way.
  • Engaging with your online appointment provider
    As your Practice works through the COVID-19 vaccine rollout, it is important to notify your online appointment vendor if any configuration changes are needed. This will ensure that your phone/in person booking process mirrors the process used when making an online appointment.

We appreciate that this vaccine rollout requires Practices to manage lots of moving pieces. 

To assist you, we’ve made a recording of our recent COVID-19 Vaccine Rollout Webinar available on our Vimeo channel or view it below, and further information on the rollout can be found on the Bp Premier Knowledge Base, which is accessible from within Bp Premier by selecting Help > Online.

Authored by:

Jessica White Author Blog Picture

Jessica White
Manager of Commercial & Customer Enablement at Best Practice Software

Share this article:

Prescribing Medication by Active Ingredient – 8 Weeks On

Prescribing medication by active ingredient article calendar on red background with date marked as 8 weeks with AIP

It’s now been approximately 8 weeks since the Australian government mandated that those prescribing medication needed to include the active ingredient names when preparing a prescription.

The introduction of active ingredient prescribing from the 1st of February 2021 presented many doctors with considerable changes to the way they were prescribing medication. The legislation requires prescriptions to include a medication’s active ingredient first, then optionally followed by the brand name. This means that prescriptions can no longer only have the brand name listed, unless they are included in the “List of Excluded Medicinal Items” (LEMI).

A significant amount of groundwork was required for software vendors to implement the changes. Medical Practices across Australia had to upgrade their prescription generating software to ensure they were meeting their legislative obligations.

Prescribing Medication by Active Ingredient

Prescribing Medication by Active Ingredient - Dr. Fabrina Weighs in 8 Weeks On

 

Most Practice management software solutions provide easy and seamless processes to prescribe new medication and re-prescribe existing medication. The new legislation now requires doctors to add additional steps to their existing workflow when prescribing medication if they want their patient to have a specific brand dispensed by the pharmacist. As with all systemic changes, major or minor, there were significant challenges faced by doctors with the introduction of this change.

In the early days of the changeover, it was common to omit the additional step to check the “Print Brand Name on Script” field and as a result, prescriptions that should have had the brand name listed only had the active ingredient printed. This posed potential dangers especially for medications such as insulin with a narrow therapeutic window, and for the combined oral contraceptive pill with multiple brands with the same active ingredient that are not necessarily interchangeable. While these medications are not in the aforementioned “List of Excluded Medicinal Items” (and therefore software vendors could not automatically print the brand on the script), they are included in the government’s “List of Medications for Brand Consideration” (LMBC). The LMBC is a list of medications the government has deemed that, due to safety reasons, should be prescribed by brand name.

In Bp Premier, when prescribing medication, there is now a warning message that highlights if a brand name should be considered – this is based on the LMBC list mentioned above:

Prescribing medication in Bp Premier brand name warning

This change has obligated doctors to have discussions with their patients about their medication, the active ingredient name and if there is a clinical or non-clinical reason why they should be taking a specific brand. 

Some common clinical reasons why a brand should be prescribed can include, but are not limited to; medications that are not bioequivalent such as Eltroxin and Eutroxig/Oroxine; different medication formulations such as extended release or immediate release; drugs with different dosing frequency, for example, certain oestrogen patches; allergies or intolerances to other additives such as gluten or lactose; and patient specific idiosyncratic reactions. 

Non-clinical reasons why doctors may wish to prescribe by brand name for certain populations such as those with low literacy rates, disabilities or those coming from culturally and linguistically diverse backgrounds who may find it easier to identify their medications by its packaging.  If there are no compelling reasons to continue with a specific brand, we should discuss the option to switch to a generic brand thereby facilitating informed decision making by the patient.

Although generic medications have been available in Australia for many years, some patients still have misconceptions regarding perceived poor quality and therefore reduced efficacy and safety of generic medication. It should be stressed that generic medications are not akin to “home brand” items found in supermarkets as these medications have been approved by the TGA and are deemed to be bioequivalent and just as safe and efficacious as their brand-named counterparts by clinical studies. While these discussions naturally add to our consult time, they are important to aide in patients overall understanding of their condition and treatment plan when prescribing medication.

As predicted by the Department of Health, this change will achieve several benefits to both patients and taxpayers. It is envisaged that active ingredient prescribing will increase consumer health literacy and make communication less ambiguous thereby reducing the risk of patients doubling up on medications or omitting to take them by mistake. There will also be a significant reduction in the cost of medications to patients and improvement in the financial sustainability of the PBS and RPBS with the increased uptake of generic medication.

The use of active ingredient prescribing is already implemented in hospitals nationwide and the extension to primary and community-based care was inevitable. While patients, doctors and pharmacies faced some hurdles initially, for the most part these have been overcome with diligence.

For more information, read our article discussing what active ingredient prescribing means for you.

Authored by:

Dr Fabrina Avatar

Dr. Fabrina Hossain
Clinical Advisor at Best Practice Software

Share this article: